Vertex Pharmaceuticals VRTX
NASDAQ VRTX
$522.38 +6.04 (+1.17%)
At close: Sep 24, 2026 · 4:00 PM EDT

Vertex Pharmaceuticals (VRTX) Restructuring Costs (2009 - 2018)

Vertex Pharmaceuticals (VRTX) posted Restructuring Costs of -$4000.0 for Q4 2018, down 102.3% on a QoQ basis from $174000.0 in Q3 2018, and down 101.03% year-over-year from $387000.0 in Q4 2017.

Analysis

Vertex Pharmaceuticals (VRTX) Restructuring Costs (2009 - 2018) Analysis & Trends

Vertex Pharmaceuticals has reported Restructuring Costs for 10 years, with the latest figure at -$4000.0 in Q4 2018.

  • On a quarterly basis, Restructuring Costs fell 101.03% year-over-year to -$4000.0 in Q4 2018; TTM through Sep 2019 was -$4000.0, a 100.7% decrease from a year earlier, with the FY2018 full-year figure at -$184000.0, down 101.29% from the prior year.
  • Restructuring Costs was -$4000.0 for Q4 2018 at Vertex Pharmaceuticals, down from $174000.0 in the prior quarter.
  • The five-year high for Restructuring Costs was $40.8 million in Q3 2014, with the low at -$3.3 million in Q1 2015.
  • Average Restructuring Costs over 5 years is $3.4 million, with a median of $365000.0 recorded in 2016.
  • The sharpest annual moves came in 2014 and 2015: Restructuring Costs surged 15766.67% in 2014, then sank 152.88% in 2015.
  • Over 5 years, Restructuring Costs stood at $4.2 million in 2014, then sank by 63.4% to $1.5 million in 2015, then tumbled by 85.3% to $224000.0 in 2016, then surged by 72.77% to $387000.0 in 2017, then slumped by 101.03% to -$4000.0 in 2018.
  • The last three Restructuring Costs figures came in at -$4000.0 (Q4 2018), $174000.0 (Q3 2018), and -$62000.0 (Q2 2018), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 649.01 Bn 628.25 Bn 17.26 Bn
2 AbbVie 468.55 Bn 462.03 Bn 12.70 Bn
3 Merck 365.49 Bn 358.40 Bn 12.21 Bn
4 Novartis Ag 272.39 Bn 265.10 Bn 11.24 Bn
5 Astrazeneca 253.18 Bn 247.96 Bn 12.86 Bn
6 Amgen 219.53 Bn 205.54 Bn 7.24 Bn
7 Gilead Sciences 187.85 Bn 184.59 Bn 6.22 Bn
8 Pfizer 160.56 Bn 149.16 Bn 10.94 Bn
9 Vertex Pharmaceuticals 130.81 Bn 122.96 Bn 2.84 Bn
10 Bristol Myers Squibb 124.95 Bn 113.89 Bn 9.25 Bn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2018 -4,000.00
Sep 30, 2018 174,000.00
Jun 30, 2018 -62,000.00
Mar 31, 2018 76,000.00
Dec 31, 2017 387,000.00
Sep 30, 2017 337,000.00
Jun 30, 2017 3.52 Mn
Mar 31, 2017 10.00 Mn
Dec 31, 2016 224,000.00
Sep 30, 2016 8,000.00
Jun 30, 2016 343,000.00
Mar 31, 2016 687,000.00
Dec 31, 2015 1.52 Mn
Sep 30, 2015 1.83 Mn
Jun 30, 2015 2.13 Mn
Mar 31, 2015 -3.27 Mn
Dec 31, 2014 4.16 Mn
Sep 30, 2014 40.84 Mn
Jun 30, 2014 -270,000.00
Mar 31, 2014 6.19 Mn
API Access

Vertex Pharmaceuticals Restructuring Costs API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=restructuring-costs&ticker=VRTX&period=max&api_key=YOUR_API_KEY